Evidence map›Paper›PMID 27364561›Full record

ArticleEnvironmental and molecular mutagenesis2016

γH2AX and p53 responses in TK6 cells discriminate promutagens and nongenotoxicants in the presence of rat liver S9.

Derek T Bernacki, Steven M Bryce, Jeffrey C Bemis, David Kirkland, Stephen D Dertinger

Abstract read
In one paragraph

Article in Environmental and molecular mutagenesis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Aneugen Molecular Mechanism Assay: Proof-of-Concept With 27 Reference Chemicals.Toxicological sciences : an official journal of the Society of Toxicology · 2019
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Derek T Bernacki *Litron Laboratories, 3500 Winton Place, Rochester, New York, 14623, USA.
Steven M Bryce *Litron Laboratories, 3500 Winton Place, Rochester, New York, 14623, USA.
Jeffrey C BemisLitron Laboratories, 3500 Winton Place, Rochester, New York, 14623, USA.
David KirklandKirkland Consulting, Tadcaster, UK.
Stephen D DertingerLitron Laboratories, 3500 Winton Place, Rochester, New York, 14623, USA.
Litron Laboratories (United States) · USLancaster University · GB

Funding

Biomarker Matrix for Genotoxicity Mode of ActionR44ES024039 · NIEHS · LITRON LABORATORIES, LTD. · PI BEMIS, JEFFREY C, DERTINGER, STEPHEN D · 2014 to 2016
$1.1M
NIEHS NIH HHS R44 ES024039
6 · The paper itself

Abstract

Previous work with a diverse set of reference chemicals suggests that an in vitro multiplexed flow cytometry-based assay (MultiFlow™ DNA Damage Kit-p53, γH2AX, Phospho-Histone H3) can distinguish direct-acting clastogens and aneugens from nongenotoxicants (Bryce SM et al. []: Environ Mol Mutagen 57:171-189). This work extends this line of investigation to include compounds that require metabolic activation to form reactive electrophiles. For these experiments, TK6 cells were exposed to 11 promutagens and 37 presumed nongenotoxicants in 96 well plates. Unless precipitation or foreknowledge about cytotoxicity suggested otherwise, the highest concentration was 1 mM. Exposure occurred for 4 hr after which time cells were washed to remove S9 and test article. Immediately following the wash and again at 24 hr, cell aliquots were added to wells of a microtiter plate containing the working detergent/stain/antibody cocktail. After a brief incubation, robotic sampling was employed for walk-away flow cytometric data acquisition. Univariate logistic regression analyses indicated that γH2AX induction and p53 activation provide the greatest degree of discrimination between clastogens and nongenotoxicants. Multivariate prediction algorithms that incorporated both of these endpoints, in each combination of time points, were evaluated. The best performing models correctly predicted 9 clastogens out of 11 and 36 nongenotoxicants out of 37. These results are encouraging as they suggest that an efficient and highly scalable multiplexed assay can effectively identify clastogenic chemicals that require bioactivation. More work is planned with a broader range of chemicals, additional cell lines, and other laboratories to further evaluate the merits and limitations of this approach. Environ. Mol. Mutagen. 57:546-558, 2016. © 2016 Wiley Periodicals, Inc.

Indexed as

Activation, MetabolicAneugensAnimalsBiomarkersCell Culture TechniquesCell Line, TumorCell SurvivalFlow CytometryHistonesHumansLiverLogistic ModelsMutagenicity TestsMutagensRatsSupervised Machine LearningAneugensBiomarkersH2AX protein, humanHistonesMutagensTumor Suppressor Protein p53flow cytometrygenotoxicitymetabolic activationp53γH2AX

Identifiers

PMID27364561
PMCPMC4980245
OpenAlexW2471456131

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.